Rapid replacement by non-vaccine pneumococcal serotypes may mitigate the impact of the pneumococcal conjugate vaccine on nasopharyngeal bacterial ecology.
Document Type
Article
Publication Date
8-15-2017
JAX Source
Sci Rep 2017 Aug 15; 7(1):8127.
Volume
7
Issue
1
First Page
8127
Last Page
8127
ISSN
2045-2322
PMID
28811633
DOI
https://doi.org/10.1038/s41598-017-08717-0
Abstract
There is growing concern that interventions that alter microbial ecology can adversely affect health. We characterised the impact of the seven-valent pneumococcal conjugate vaccine (PCV7) on pneumococcal carriage and the bacterial component of the nasopharyngeal microbiome during infancy. Newborns were recruited into three groups as follows: Group1 (n = 33) was the control group and comprised infants who received PCV7 after 6 months and came from unvaccinated communities. Group 2 (n = 30) came from unvaccinated communities and Group 3 (n = 39) came from vaccinated communities. Both group 2 and 3 received PCV7 at 2, 3 and 4 months. Culture and 16 S rRNA gene sequencing were performed on nasopharyngeal specimens collected at regular intervals from infants. Nasopharyngeal carriage of PCV7 serotypes in Group 1 was significantly higher than in Group 2 and 3 (p < 0.01). However, pneumococcal carriage remained comparable due to an expansion of non-vaccine serotypes in Groups 2 and 3. Determination of phylogenetic dis(similarities) showed that the bacterial community structures were comparable across groups. A mixed effects model showed no difference in community richness (p = 0.15) and Shannon α-diversity (p = 0.48) across the groups. Immediate replacement of pneumococcal vaccine serotypes with non-vaccine serotypes may mitigate the impact of PCV7 on nasopharyngeal bacterial community structure and ecology. Sci Rep 2017 Aug 15; 7(1):8127.
Recommended Citation
Kwambana-Adams B,
Hanson B,
Worwui A,
Agbla S,
Foster-Nyarko E,
Ceesay F,
Ebruke C,
Egere U,
Zhou Y,
Ndukum M,
Weinstock E,
Barer M,
Adegbola R,
Weinstock GM,
Antonio M.
Rapid replacement by non-vaccine pneumococcal serotypes may mitigate the impact of the pneumococcal conjugate vaccine on nasopharyngeal bacterial ecology. Sci Rep 2017 Aug 15; 7(1):8127.